Sangel Capital
Overview
Established in 2010, Sangel Capital is one of China's earliest professional biomedical venture capital institutions, focusing on life science and technology. The firm has offices in Shenzhen, Beijing, Suzhou, and Chicago, bringing together a team of industry experts, scientists, and investors to manage a series of RMB and USD funds. Sangel Capital specializes in investing in startups within the biotech, biopharma, medical devices, and digital health sectors. The firm's investment strategy emphasizes identifying promising startups with high return potential and assisting them in reaching their full growth potential. Over the years, Sangel Capital has earned multiple awards from national organizations, reflecting its strong presence in the venture capital community. The firm's founder, Liu Mulong, was recognized as one of China's top early-stage investors in 2021 by the ChinaVenture Awards, highlighting Sangel Capital's significant role in the biomedical investment industry.
Investment Focus
- Innovative life science technologies
- High return potential
- Strong growth prospects
Portfolio Companies
Reach Sangel Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sangel Capital
What sectors does Sangel Capital invest in?
Sangel Capital invests in Digital Health, Medical Devices, Biotech and Biopharma, and is based in Shenzhen, China. Sangel Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Sangel Capital invest at?
Sangel Capital backs companies at Seed, Early Stage and Late Stage, writing cheques of 1M - 50M.
Which regions does Sangel Capital invest in?
Sangel Capital invests across United States and China.
Who are the partners at Sangel Capital?
Team members listed for Sangel Capital include Jeremy Chen (Partner) and JianLin Fung (Senior Partner).
What companies has Sangel Capital invested in?
Sangel Capital's portfolio includes Huaheng Biotech, Sirnaomics Ltd, 3D-Medicines, InnerMed, Yinyi Biotech, Ascentawits Pharmaceuticals and Magpie Pharmaceuticals.
How do I contact Sangel Capital?
Sangel Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
